AstraZeneca Profit Margin 2006-2019 | AZN

Current and historical gross margin, operating margin and net profit margin for AstraZeneca (AZN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AstraZeneca net profit margin as of June 30, 2019 is 9.38%.
AstraZeneca Annual Profit Margins
AstraZeneca Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $113.163B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $342.221B 14.90
Roche Holding AG (RHHBY) Switzerland $240.930B 0.00
Merck (MRK) United States $211.257B 17.37
Pfizer (PFE) United States $201.883B 11.89
Novartis AG (NVS) Switzerland $198.525B 17.07
Novo Nordisk (NVO) Denmark $120.697B 21.33
Sanofi (SNY) France $110.933B 13.63
Eli Lilly (LLY) United States $107.279B 20.02
AbbVie (ABBV) United States $105.859B 8.48
GlaxoSmithKline (GSK) United Kingdom $102.512B 12.88
Bristol-Myers Squibb (BMY) United States $81.363B 11.54
Bayer (BAYRY) Germany $69.195B 10.08
H Lundbeck (HLUYY) Denmark $6.741B 9.73